BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9678629)

  • 1. Tamoxifen-induced sexual dysfunction in a breast cancer patient: a case report.
    Barni S; Ardizzoia A
    Tumori; 1998; 84(3):417-8. PubMed ID: 9678629
    [No Abstract]   [Full Text] [Related]  

  • 2. Co-occurrence of atypical endometriosis, subserous uterine leiomyomata, sactosalpinx, serous cystadenoma and bilateral hemorrhagic corpora lutea in a perimenopausal adipose patient taking tamoxifen (20 mg/day) for invasive lobular breast cancer.
    Ebert AD; Rosenow G; David M; Mechsner S; Magalov IS; Papadopoulos T
    Gynecol Obstet Invest; 2008; 66(3):209-13. PubMed ID: 18645252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fatal hypercalcemia in tamoxifen. Chief symptom: increasing somnolence in a 68-year-old patient].
    Mayer O; Hricko P; Bernhard P; Leibundgut U
    Praxis (Bern 1994); 1999 Nov; 88(46):1923-4. PubMed ID: 10593148
    [No Abstract]   [Full Text] [Related]  

  • 4. Microinvasive lobular carcinoma of the breast.
    Howat AJ; Armour A; Ellis IO
    Histopathology; 2000 Nov; 37(5):477-8. PubMed ID: 11119139
    [No Abstract]   [Full Text] [Related]  

  • 5. [Lobular carcinoma-in-situ and ductal hyperplasia of breast].
    Fu L
    Zhonghua Bing Li Xue Za Zhi; 2006 Jan; 35(1):4-7. PubMed ID: 16608640
    [No Abstract]   [Full Text] [Related]  

  • 6. Breast cancer response.
    Swords EP
    Am J Nurs; 2001 Aug; 101(8):13; author reply 13-4. PubMed ID: 12113005
    [No Abstract]   [Full Text] [Related]  

  • 7. [The interruption of a study following an "ad interim" analysis. The example of the NSABP-P1 study].
    Savarese A
    Suppl Tumori; 2004; 3(4):S23-4. PubMed ID: 15206204
    [No Abstract]   [Full Text] [Related]  

  • 8. Metastatic breast lobular carcinoma involving tamoxifen-associated endometrial polyps: report of two cases and review of tamoxifen-associated polypoid uterine lesions.
    Houghton JP; Ioffe OB; Silverberg SG; McGrady B; McCluggage WG
    Mod Pathol; 2003 Apr; 16(4):395-8. PubMed ID: 12692205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen-induced radiation recall dermatitis.
    Kundranda MN; Daw HA
    Am J Clin Oncol; 2006 Dec; 29(6):637-8. PubMed ID: 17149005
    [No Abstract]   [Full Text] [Related]  

  • 10. [A case of combined noninvasive ductal and lobular carcinoma].
    Nagashima S; Sakurai K; Suzuki S; Hara Y; Waga E; Iizuka M; Fuchinoue T; Hirano T; Enomoto K; Tani M; Masuda S; Amano S; Koshinaga T
    Gan To Kagaku Ryoho; 2012 Nov; 39(12):2033-5. PubMed ID: 23267967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Severe acute pancreatitis due to tamoxifen-induced hypertriglyceridemia.
    Yoneyama K; Nakagawa M
    Breast J; 2019 Jul; 25(4):788-789. PubMed ID: 31044481
    [No Abstract]   [Full Text] [Related]  

  • 12. Tamoxifen-induced hepatotoxicity.
    Ahbeddou N; Belbaraka R; Fetohi M; Errihani H
    Indian J Cancer; 2011; 48(3):385. PubMed ID: 21921356
    [No Abstract]   [Full Text] [Related]  

  • 13. Tamoxifen induced-thrombocytopenia: it does occur.
    Nasiroğlu N; Pamukçuoğlu M; Abali H; Oksüzoğlu B; Uner A; Zengin N
    Med Oncol; 2007; 24(4):453-4. PubMed ID: 17917098
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen in the treatment of breast cancer.
    Osborne CK
    N Engl J Med; 1998 Nov; 339(22):1609-18. PubMed ID: 9828250
    [No Abstract]   [Full Text] [Related]  

  • 15. High-grade endometrial stromal sarcoma following tamoxifen treatment.
    Engin H
    Gynecol Oncol; 2008 Jan; 108(1):253-4. PubMed ID: 17928038
    [No Abstract]   [Full Text] [Related]  

  • 16. Thymic malignancy in a breast cancer patient--is there an association with anti-estrogenic effects of tamoxifen?
    Oyan B; Aksoy S; Yavas O; Kars A; Turker A; Barista I
    Acta Oncol; 2004; 43(1):115-6. PubMed ID: 15068330
    [No Abstract]   [Full Text] [Related]  

  • 17. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
    Fisher B; Dignam J; Wolmark N; Wickerham DL; Fisher ER; Mamounas E; Smith R; Begovic M; Dimitrov NV; Margolese RG; Kardinal CG; Kavanah MT; Fehrenbacher L; Oishi RH
    Lancet; 1999 Jun; 353(9169):1993-2000. PubMed ID: 10376613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine metastases from breast cancer in a patient under tamoxifen therapy. Case report.
    Dessole S; Cherchi PL; Ruiu GA; Meloni GB; Cossu Rocca P
    Eur J Gynaecol Oncol; 1999; 20(5-6):416-7. PubMed ID: 10609509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ultrasound, tamoxifen and endometrial carcinoma.
    Ghirardini G; Bianchini A; Rossi GP
    Ultrasound Obstet Gynecol; 1999 May; 13(5):375-6. PubMed ID: 10380310
    [No Abstract]   [Full Text] [Related]  

  • 20. [Massive pleural effusion after surgery of breast cancer and early discontinuation of tamoxifen: about an observation].
    Ngombe LK; Kangulu IB; Nday CM; Tshanda MN; Ngoy Lumbule J; Matanga PM; Sampatwa ON; Nzaji MK
    Pan Afr Med J; 2014; 17():129. PubMed ID: 25374634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.